329 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Portlock
    Portlock
  4. Moskowitz
    Moskowitz
  5. Noy
    Noy
  6. Straus
    Straus
  7. Yahalom
    Yahalom
  8. Moskowitz
    Moskowitz
  9. Palomba
    Palomba
  10. Matasar
    Matasar

Groups

  1. Center for Hematologic Malignancies (329)
  2. Department of Medicine (329)
  3. Hematologic Malignancies, Division of (329)
  4. Lymphoma (329)
  5. Population Sciences Research Program (86)
  6. Survivorship Research (86)
  7. Epidemiology and Biostatistics (55)
  8. Biostatistics Service (49)
  9. Radiation Oncology, Department of (45)
  10. Sloan Kettering Institute Faculty (42)
  1. "adult"
  2. "Lymphoma"
Formats
  1. Journal Article (308)
  2. Research Letter (8)
  3. Review (5)
  4. Conference Paper (4)
  5. Correspondence (2)
  6. Book Section (1)
  7. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (329)
  2. Department of Medicine (329)
  3. Hematologic Malignancies, Division of (329)
  4. Lymphoma (329)
  5. Population Sciences Research Program (86)
  6. Survivorship Research (86)

More Groups

People
  1. Andrew Zelenetz (101)
  2. David Straus (85)
  3. Steven Horwitz (71)
  4. Carol Portlock (65)
  5. Craig Moskowitz (64)
  6. Ariela Noy (57)

More People

Years
  1. 2024 (7)
  2. 2023 (19)
  3. 2022 (21)
  4. 2021 (10)
  5. 2020 (26)
  6. 2019 (13)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Blood (40)
  3. Leukemia and Lymphoma (32)
  4. Cancer (27)
  5. British Journal of Haematology (19)
  6. Annals of Oncology (12)

More Publications

Publishers
  1. American Society of Hematology (53)
  2. American Society of Clinical Oncology (43)
  3. Taylor & Francis Group (37)
  4. Wiley Blackwell (30)
  5. Elsevier Inc. (28)
  6. John Wiley & Sons (20)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1
    Research Letter

    Crosswell, H. E.; LaCasce, A. S.; Bartlett, N. L.; Straus, D. J.; Savage, K. J.; Zinzani, P. L.; Collins, G. P.; Fanale, M.; Fenton, K.; Dong, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Does BTKi improve CAR T-cell therapy in MCL?
    Editorial

    Boardman, A. P.; Palomba, M. L.
    Blood (2024)

    Fulltext@MSK | Save
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
    Journal Article

    Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M.; Wang, M.; Arnason, J.; Purev, E.; Maloney, D. G.; Andreadis, C.; Sehgal, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Surgical management and long-term outcomes of BIA-ALCL: A multidisciplinary approach
    Journal Article

    Vorstenbosch, J.; Ghione, P.; Plitas, G.; Horwitz, S.; Kim, M.; Cordeiro, P.; Nelson, J.; McCarthy, C.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma
    Journal Article

    Grieve, C.; Joseph, A.; Drullinsky, P.; Zelenetz, A. D.; Hamlin, P.; Kumar, A.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Research Letter

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G. T.; Romancik, J.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schòˆder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement
    Journal Article

    Ryan, C. E.; Zon, R. L.; Redd, R.; Fisher, D. C.; Shouval, R.; Kumar, A.; Crombie, J. L.; Sadrzadeh, H.; Kim, A. I.; Nayak, L.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save